oei-al or sminia-p or thijssen-vl* or franken-na* - Search Results

Year	Number of Results
1981	1
1982	2
1983	2
1984	1
1985	2
1986	2
1987	1
1988	1
1989	2
1990	2
1991	5
1992	3
1993	3
1994	1
1995	4
1996	4
1997	6
1998	5
1999	4
2000	7
2001	9
2002	10
2003	5
2004	13
2005	12
2006	15
2007	18
2008	13
2009	9
2010	8
2011	10
2012	11
2013	18
2014	15
2015	14
2016	13
2017	14
2018	14
2019	11
2020	15
2021	17
2022	22
2023	16
2024	10
2025	7

1

Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification.

van der Gaag S, Jordens T, Yaqub M, Grijseels R, van Valkengoed DW, de Langen EN, van den Broek R, Thijssen VLJL, de Langen AJ, Kouwenhoven MCM, Bahce I, Westerman BA, Hendrikse NH, Bartelink IH. van der Gaag S, et al. CPT Pharmacometrics Syst Pharmacol. 2025 Feb 26. doi: 10.1002/psp4.70006. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2025. PMID: 40009553 Free article.

2

Computational Evaluation of Improved HIPEC Drug Delivery Kinetics via Bevacizumab-Induced Vascular Normalization.

Namakshenas P, Crezee J, Tuynman JB, Tanis PJ, Oei AL, Kok HP. Namakshenas P, et al. Pharmaceutics. 2025 Jan 23;17(2):155. doi: 10.3390/pharmaceutics17020155. Pharmaceutics. 2025. PMID: 40006522 Free PMC article.

3

Corrigendum to 'Investigating the delivery of PD-L1-targeted immunoliposomes in a dynamic cervical cancer-on-a-chip model' [Journal of Controlled Release Volume 379, 10 March 2025, Pages 236-250].

Fobian SF, Amin M, Sacchetti A, Seynhaeve ALB, Oei AL, Ten Hagen TLM. Fobian SF, et al. J Control Release. 2025 Apr 10;380:1202. doi: 10.1016/j.jconrel.2025.01.089. Epub 2025 Feb 7. J Control Release. 2025. PMID: 39920015 Free article. No abstract available.

4

Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity.

Nuijens AC, Oei AL, Franken NAP, Rasch CRN, Stalpers LJA. Nuijens AC, et al. Curr Oncol. 2025 Jan 17;32(1):47. doi: 10.3390/curroncol32010047. Curr Oncol. 2025. PMID: 39851963 Free PMC article. Review.

5

Addition of PARP1-inhibition enhances chemoradiotherapy and thermoradiotherapy when treating cervical cancer in an in vivo mouse model.

IJff M, Mei X, Scutigliani EM, Rodermond HM, van Bochove GGW, Krawczyk PM, Franken NAP, Stalpers LJA, Crezee J, Oei AL. IJff M, et al. Int J Hyperthermia. 2025 Dec;42(1):2450514. doi: 10.1080/02656736.2025.2450514. Epub 2025 Jan 21. Int J Hyperthermia. 2025. PMID: 39837264 Free article.

6

Outcomes of endometrial cancer prevention strategies in patients with Lynch syndrome: a nationwide cohort study in the Netherlands.

Eikenboom EL, van Leeuwen L, Groenendijk F, Woolderink JM, Van Altena AM, Van Leerdam ME, Spaander MCW, van Doorn HC, Wagner A; collaborative investigators from the Dutch Foundation for Detection of Hereditary Tumors. Eikenboom EL, et al. EClinicalMedicine. 2024 Dec 21;79:103006. doi: 10.1016/j.eclinm.2024.103006. eCollection 2025 Jan. EClinicalMedicine. 2024. PMID: 39816931 Free PMC article.

7

Investigating the delivery of PD-L1-targeted immunoliposomes in a dynamic cervical cancer-on-a-chip model.

Fobian SF, Amin M, Sacchetti A, Oei AL, Ten Hagen TLM. Fobian SF, et al. J Control Release. 2025 Mar 10;379:236-250. doi: 10.1016/j.jconrel.2025.01.014. Epub 2025 Jan 11. J Control Release. 2025. PMID: 39798703 Free article.

8

Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: lower toxicity rates reduce the predictive value of γ-H2AX foci decay ratio in patients undergoing pelvic radiotherapy.

Nuijens AC, Oei AL, Koster L, Hoebe RA, Franken NAP, Rasch CRN, Stalpers LJA. Nuijens AC, et al. Radiat Oncol. 2024 Sep 2;19(1):116. doi: 10.1186/s13014-024-02501-x. Radiat Oncol. 2024. PMID: 39223539 Free PMC article.

9

Vascular galectins in tumor angiogenesis and cancer immunity.

Thijssen VLJL. Thijssen VLJL. Semin Immunopathol. 2024 Jul 11;46(1-2):3. doi: 10.1007/s00281-024-01014-9. Semin Immunopathol. 2024. PMID: 38990363 Free PMC article. Review.

10

Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review.

Fobian SF, Mei X, Crezee J, Snoek BC, Steenbergen RDM, Hu J, Ten Hagen TLM, Vermeulen L, Stalpers LJA, Oei AL. Fobian SF, et al. J Med Virol. 2024 Jun;96(6):e29741. doi: 10.1002/jmv.29741. J Med Virol. 2024. PMID: 38922964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

341 results

Results by year